IL10 and myeloid sarcoma: This concept is supported by observations in the commonly used experimental autoimmune encephalomyelitis (EAE) model of MS, where it has been shown that B cell-derived interleukin (IL)-6 and IL-10 can respectively enhance or suppress EAE disease activity [7]–[10].